Uma Mahadevan, MD

Professor

Uma Mahadevan, MD
Lynne and Marc Benioff Professor of Gastroenterology
University of California, San Francisco
Director, UCSF Center for Colitis and Crohn's Disease
Website: IBD.UCSF.EDU
Twitter: @UmaMahadevanIBD

Dr. Uma Mahadevan is the Lynne and Marc Benioff Professor of Gastroenterology, Director of the Colitis and Crohn's Disease Center and Director of the Advanced IBD Fellowship at the University of California, San Francisco. She specializes in inflammatory bowel disease (IBD), particularly pregnancy and drug safety. She completed a medical degree at the State University of New York in Brooklyn, residency in internal medicine at Mount Sinai Medical Center in New York, Fellowship in gastroenterology at UCSF, and Advanced fellowship in IBD at the Mayo Clinic, Rochester, Minnesota. For her exceptional work in pregnancy and drug safety and her mentoring of GI fellows and junior faculty she received the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award and the 2022 Sherman Prize.
Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she was Chair for the IMIBD Section, Chair of the AGA National IBD Parenthood initiative and Director (2023) and co-Director (2022, 2017) of the AGA Postgraduate Course. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee. She was Chair of the Crohns Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress (2020). Dr. Mahadevan is a member of the International Organization of IBD (IOIBD) for which she serves on the nominating committee.
Dr. Mahadevan has served on many prestigious journals, including special section editor for Gastroenterology. Dr. Mahadevan has published over 100 original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, Gut, Nature Reviews, American Journal of Gastroenterology, Inflammatory Bowel Diseases, and Lancet Gastroenterology Hepatology as well as several book chapters. She authored the joint AGA, Society of Maternal Fetal Medicine Clinical Care Pathway on the Management of IBD in Pregnancy.
Dr. Mahadevan is a global expert on the management of pregnancy and drug safety in the patient with IBD. She is also interested in the role of diet and IBD and has an ongoing original study in this area. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO) and a clinical trial on the impact of nutritional interventions in the management of IBD (SEAMUS). She has an interest in digital health and lead the transition of the GI Division to telemedicine at the start of the pandemic in March 2020 and has developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF. Dr. Mahadevan is proud to have mentored several Advanced IBD Fellows who know hold key roles in IBD Centers around the United States.

Education
Inflammatory Bowel Disease, 2001 - , Mayo Clinic, Rochester, MN
Gastroenterology, 2001 - , University of California, San Francisco
Internal Medicine, 1998 - , Mount Sinai School of Medicine
M.D., 1995 - , SUNY Brooklyn
Honors and Awards
  • IMIBD Research Mentor Award, American Gastroenterology Association, 2022
  • Sherman Prize: Innovator for Life, Bruce and Cynthia Sherman Foundation, 2022
  • Catalyst for Mission Advancement, Crohn's Colitis Foundation, Bay Area, 2021
  • Innovator Award, Crohn's Colitis Foundation, 2020
  • Best Doctors in America/ San Francisco, Castle Connelly, 2008-2023
Websites
Publications
  1. Kohli A, Long MD, Beaulieu DB, Kane SV, Mahadevan U. Long-term Infant Outcomes After In Utero Biologic Exposure: Results from the Pregnancy Inflammatory Disease Neonatal Outcomes (PIANO) Registry. The American journal of gastroenterology 2026. PMID: 41789805


  2. Mahadevan U, Sands BE, Ha C, Yimgang D, Yue E, Huisingh C, Law L, Holweg CTJ, Wegrzyn L, Dubinsky M. Epidemiology and Treatment of Inflammatory Bowel Disease in Pregnancy: Results from a Retrospective, Observational Study. Digestive diseases and sciences 2026. PMID: 41739324


  3. Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G, Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricova D, Dubinsky M, Long M, Global Consensus Group for Pregnancy in IBD. Global consensus statement on the management of pregnancy in inflammatory bowel disease. Gut 2025. PMID: 40876906


  4. Ahmad OF, Mori Y, Bretthauer M, Dourado DA, Hassan C, Bisschops R, Bhandari P, Byrne MF, Dekker E, Mahadevan U, May FP, Messmann H, Misawa M, Ogata H, Saito Y, Silverman AL, Wang P, Yano T, Aabakken L, Berzin TM. The Legal and Ethical Framework for Artificial Intelligence in Gastrointestinal Endoscopy: A World Endoscopy Organization International Consensus Statement. Annals of internal medicine 2025. PMID: 41359967


  5. Casanova MJ, Gisbert JP, Amiot A, Gordon H, Fiorino G, Flanagan E, Kotze PG, Sokic-Milutinovic A, Sonnenberg E, Nuñez P, Blesl A, Catalán-Serra I, Bossuyt P, Filip R, Bar-Gil Shitrit A, Kagramanova A, Krznaric Z, Molander P, Mantzaris GJ, Juillerat P, Molnar T, Gecse KB, Torres J, Myrelid P, Mahadevan U, Márquez JR, Iade-Vergara BM, Rausch A, Duricova D, Julsgaard M, Chaparro M. International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for Improvements. United European gastroenterology journal 2025. PMID: 41085090


  6. Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G, Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricova D, Dubinsky M, Long M, Global Consensus Group for Pregnancy and IBD. Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease. Inflammatory bowel diseases 2025. PMID: 40874613


  7. Mahadevan U, Chaparro M, Segovia M, Guo X, Kulisek N, Wu J, Vranic I, Diehl A, Kavanaugh A, Dubinsky M. Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs. The American journal of gastroenterology 2025. PMID: 41002213


  8. Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G, Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricova D, Dubinsky M, Long M, Global Consensus Group for Pregnancy and IBD. Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease. Journal of Crohn's & colitis 2025. PMID: 40914850


  9. Mahadevan U, Jairath V, Begun J, Pudipeddi A, Garg M, De Cruz P, Li Wai Suen CFD, Choy MC, Con D, Vaughan R, Chetwood JD, Clark DA, Haifer C, Sparrow MP, Leong R, Mountifield R. IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia. Journal of gastroenterology and hepatology 2025. PMID: 41069245


  10. Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G, Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricova D, Dubinsky M, Long M, Global Consensus Group for Pregnancy and IBD. Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease. Alimentary pharmacology & therapeutics 2025. PMID: 40874657


  11. Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G, Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricova D, Dubinsky M, Long M, Global Consensus Group for Pregnancy and IBD. Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2025. PMID: 40874901


  12. Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S, Julsgaard M, Kane S, Ng S, Torres J, Watermeyer G, Yamamoto-Furusho J, Robinson C, Fisher S, Anderson P, Gearry R, Duricová D, Dubinsky M, Long M, Global Consensus Group for Pregnancy and IBD. Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease. The American journal of gastroenterology 2025. PMID: 40862489


  13. Lewin S, Long M, Cohen R, Scherl E, Wolf D, Mahadevan U. Wound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry. Inflammatory bowel diseases 2025. PMID: 39779464


  14. Karlovich N, McConnell R, Velayos F, Mahadevan U, Lewin S. Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis. Inflammatory bowel diseases 2024. PMID: 39295282


  15. Ehrlich S, Long M, Kane S, Mahadevan U. Placental Transfer of Upadacitinib Among Pregnant Women with Inflammatory Bowel Disease. Inflammatory bowel diseases 2025. PMID: 39982830


  16. Brenner EJ, Zhang X, Mahadevan U, Bryant AG, Kappelman MD, Long MD. Risk Factors for Contraceptive Failure and Unintended Pregnancy Among Women With Inflammatory Bowel Disease. Inflammatory bowel diseases 2025. PMID: 40084521


  17. Memel Z, Yu A, Fenton C, Wen T, Irani RA, Zhang L, Mahadevan U. The Effect of Low-dose Aspirin on Disease Activity in Pregnant Individuals with Inflammatory Bowel Disease. The American journal of gastroenterology 2025. PMID: 39773571


  18. Dubinsky MC, Charles L, Selmaj KW, Comi G, Krakovich A, Rosen M, van der Woude CJ, Mahadevan U. Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis. Inflammatory bowel diseases 2024. PMID: 38267826


  19. Long MD, Kane S, Beaulieu D, Abraham B, Zhang X, Mahadevan U. Use of Biosimilars to Infliximab During Pregnancy in Women With Inflammatory Bowel Disease: Results From the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Study. Clinical and translational gastroenterology 2024. PMID: 39665589


  20. Mennillo E, Lotstein ML, Lee G, Johri V, Ekstrand C, Tsui J, Hou J, Leet DE, He JY, Mahadevan U, Eckalbar W, Oh DY, Fragiadakis GK, Kattah MG, Combes AJ. Single-cell spatial transcriptomics of fixed, paraffin-embedded biopsies reveals colitis-associated cell networks. bioRxiv : the preprint server for biology 2024. PMID: 39605355


  21. Ear S, Cordero J, McConnell R, Velayos F, Mahadevan U, Lewin S. Extended Monitoring for Transition to Oral Corticosteroids in Acute Severe Ulcerative Colitis May Be Unnecessarily Prolonging Length of Stay. Digestive diseases and sciences 2024. PMID: 39495414


  22. Mahadevan U, Long M. Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease. Inflammatory bowel diseases 2024. PMID: 39216079


  23. Memel ZN, Mahadevan U. Surgical Management of Pregnant Patients with Inflammatory Bowel Disease. The Surgical clinics of North America 2024. PMID: 40015824


  24. Memel Z, Thiemann A, Dort C, Mahadevan U, Beck KR. Prevalence of Malnutrition and Micronutrient Deficiencies in Older Adults with Ulcerative Colitis. Digestive diseases and sciences 2024. PMID: 39438412


  25. ASGE IBD Endoscopy Consensus Panel, Shen B, Abreu MT, Cohen ER, Farraye FA, Fischer M, Feuerstadt P, Kapur S, Ko HM, Kochhar GS, Liu X, Mahadevan U, McBride DL, Navaneethan U, Regueiro M, Ritter T, Sharma P, Lichtenstein GR. Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel. Gastrointestinal endoscopy 2024. PMID: 39425706


  26. Field J, Fenton C, Zhang L, Brickman C, Mahadevan U. Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men. Inflammatory bowel diseases 2023. PMID: 37951596


  27. Mahadevan U, Levy G, Gensler L, Ali M, Lacerda AP, Wegrzyn L, Palac H, Bhutani-Jacques T, Long M, Clowse MEB, Kimball AB, Chambers C, Scialli AR. Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports. Drug safety 2024. PMID: 39008024


  28. Torres J, Mahadevan U. Editorial: Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy with Inflammatory Bowel Disease: Stop the Disease, not the Drug! Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024. PMID: 38878846


  29. Field J, Shah ND, Memel Z, Mahadevan U, Beck K. Exclusive Yet Effective: The Crohn's Disease Exclusion Diet as Treatment for Medication-Refractory Disease. Digestive diseases and sciences 2024. PMID: 38555328


  30. Mahadevan U, Dubinsky M, Dotan I. Our New President-Maria T. Abreu, MD, AGAF. Gastroenterology 2024. PMID: 38456870


  31. Mennillo E, Kim YJ, Lee G, Rusu I, Patel RK, Dorman LC, Flynn E, Li S, Bain JL, Andersen C, Rao A, Tamaki S, Tsui J, Shen A, Lotstein ML, Rahim M, Naser M, Bernard-Vazquez F, Eckalbar W, Cho SJ, Beck K, El-Nachef N, Lewin S, Selvig DR, Terdiman JP, Mahadevan U, Oh DY, Fragiadakis GK, Pisco A, Combes AJ, Kattah MG. Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis. Nature communications 2024. PMID: 38374043


  32. Mitrova K, Julsgaard M, Augustijns P, Cerna K, Mahadevan U, Duricova D, Pregnancy study group. Tofacitinib in pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood and Breast Milk Concentrations. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024. PMID: 38309493


  33. Odufalu FD, Sewell JL, Rudrapatna V, Somsouk M, Mahadevan U. Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center. Inflammatory bowel diseases 2023. PMID: 36943305


  34. Mennillo E, Kim YJ, Rusu I, Lee G, Dorman LC, Bernard-Vazquez F, Bain JL, Patel R, Andersen C, Rao A, Tamaki S, Tsui J, Shen A, Naser M, Eckalbar W, Cho SJ, Beck K, El-Nachef N, Lewin S, Selvig DR, Terdiman JP, Mahadevan U, Oh DY, Fragiadakis GK, Pisco A, Combes AJ, Kattah MG. Single-cell and spatial multi-omics identify innate and stromal modules targeted by anti-integrin therapy in ulcerative colitis. bioRxiv : the preprint server for biology 2023. PMID: 36711576


  35. Chugh R, Long MD, Jiang Y, Weaver KN, Beaulieu DB, Scherl EJ, Mahadevan U. Maternal and Neonatal Outcomes in Vedolizumab and Ustekinumab Exposed Pregnancies: Results from the PIANO registry. The American journal of gastroenterology 2023. PMID: 37796648


  36. Chugh R, Liu AW, Idomsky Y, Bigazzi O, Maiorano A, Medina E, Pierce L, Odisho A, Mahadevan U. A Digital Health Intervention to Improve the Clinical Care of Inflammatory Bowel Disease Patients. Applied clinical informatics 2023. PMID: 37586416


  37. Julsgaard M, Mahadevan U, Vestergaard T, Mols R, Ferrante M, Augustijns P. Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis. The lancet. Gastroenterology & hepatology 2023. PMID: 37269871


  38. Yu A, Ha NB, Shi B, Cheng YW, Mahadevan U, Beck KR. Real-World Experience with Tofacitinib Dose De-escalation in Patients with Moderate and Severe Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023. PMID: 37187323


  39. Chugh R, Braga-Neto MB, Fredrick TW, Ramos GP, Terdiman J, El-Nachef N, Loftus EV, Mahadevan U, Kane SV. Multicenter Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease. Journal of Crohn's & colitis 2022. PMID: 36272109


  40. Brondfield MN, Mahadevan U. Inflammatory bowel disease in pregnancy and breastfeeding. Nature reviews. Gastroenterology & hepatology 2023. PMID: 37002407


  41. Rudrapatna VA, Cheng YW, Feuille C, Mosenia A, Shih J, Shi Y, Roberson O, Rubin B, Butte AJ, Mahadevan U, Skomrock N, Erondu N, Chehoud C, Rahim S, Apfel D, Curran M, Khan NS, O'Brien C, Terry N, Martini BD. Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study. PloS one 2023. PMID: 36862717


  42. Hansel S, Muthusamy VR, Mahadevan U. 1TIPS AND TRICKS: STARTING YOUR OWN CONTINUING MEDICAL EDUCATION COURSE. Gastroenterology 2023. PMID: 36736705


  43. Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022. PMID: 36343846


  44. Blaisdell A, Zhou Y, Kattah MG, Fisher SJ, Mahadevan U. Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro. 2022. PMID: 35349682


  45. Chugh R, Mahadevan U. Advanced Fellowship Training in IBD: A Worthwhile Fourth Year. Digestive diseases and sciences 2022. PMID: 35879514


  46. Gu P, Luo J, Kim J, Paul P, Limketkai B, Sauk JS, Park S, Parekh N, Zheng K, Rudrapatna V, Syal G, Ha C, McGovern DP, Melmed GY, Fleshner P, Eisenstein S, Ramamoorthy S, Dulai PS, Boland BS, Grunvald E, Mahadevan U, Ohno-Machado L, Sandborn WJ, Singh S. Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. The American journal of gastroenterology 2022. PMID: 35973139


  47. Mahadevan U, Abraham NS, Lennon AM, Charabaty A, Vermeire S. Closing the gender gap: building a successful career and leadership in research as a female gastroenterologist. 2022. PMID: 35550046


  48. Nguyen NH, Luo J, Paul P, Kim J, Syal G, Ha C, Rudrapatna V, Park S, Parekh N, Zheng K, Sauk J, Limketkai B, Fleshner P, Eisenstein S, Ramamoorthy S, Melmed G, Dulai P, Boland B, Mahadevan U, Sandborn WJ, Ohno-Machado L, McGovern D, Singh S. Unplanned healthcare utilization and safety of biologic therapy in Hispanic vs. non-Hispanic patients with IBD: A CA-IBD Cohort Study. 2022. PMID: 35644340


  49. Mahadevan U, Naureckas S, Tikhonov I, Wang Y, Lin CB, Geldhof A, van der Woude CJ. Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database. 2022. PMID: 35560249


  50. Caplan A, McConnell R, Velayos F, Mahadevan U, Lewin S. Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis. 2022. PMID: 35389167


  51. Kushner T, Fairchild A, Johnson FR, Sands BE, Mahadevan U, Subramanian S, Ananthakrishnan A, Ha C, Bewtra M. Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy. 2021. PMID: 34750784


  52. Odufalu FD, Long M, Lin K, Mahadevan U, PIANO Investigators from the Crohn’s and Colitis Foundation (CCF) Clinical Research Alliance recruit. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. 2021. PMID: 34686575


  53. Cronin M, Berger TG, Cohen SH, Mahadevan U, North JP, Asch S. Cutaneous Chaetomium globosum Infection in a Vedolizumab-Treated Patient. 2021. PMID: 34735323


  54. Holubar SD, Lightner AL, Poylin V, Vogel JD, Gaertner W, Davis B, Davis KG, Mahadevan U, Shah SA, Kane SV, Steele SR, Paquette IM, Feingold DL, Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon an. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis. Diseases of the colon and rectum 2021. PMID: 33853087


  55. Roy Paladhi U, Harb AH, Daniel SG, Dawwas GK, Schnellinger EM, Wollack C, Aberra FN, Bewtra M, Green JA, Klaproth JA, Lichtenstein GR, Saxena A, Berera S, Buchner A, Mehta SJ, Osterman MT, Rashid F, Tomov V, Caldera F, Sumona S, Mahadevan U, Roy A, Nessel L, Wu GD, Bittinger K, Lewis JD. The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome. Inflammatory bowel diseases 2021. PMID: 33452800


  56. Meserve J, Luo J, Zhu W, Veeravalli N, Bandoli G, Chambers CD, Singh AG, Boland BS, Sandborn WJ, Mahadevan U, Singh S. Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases. Gastroenterology 2021. PMID: 33744307


  57. Long MD, Siegel CA, Abraham BP, Chiorean M, Mahadevan U. Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021. PMID: 33549864


  58. Mahadevan U. Overview of Pregnancy in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology 2021. PMID: 34035766


  59. Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, Cohen RD, Chambers CD, Sandborn WJ, Crohn’s Colitis Foundation Clinical Research Alliance. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. Gastroenterology 2020. PMID: 33227283


  60. Lewin S, Lees C, Regueiro M, Hart A, Mahadevan U. International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases. Journal of Crohn's & colitis 2020. PMID: 33085971


  61. Nuñez F P, Mahadevan U, Quera R, Bay C, Ibañez P. Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterologia y hepatologia 2020. PMID: 33070988


  62. Regner EH, Green AJ, Bain JL, Kattah MG, Mahadevan U. Importance of Not MSing Cerebral White Matter Disease in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences 2020. PMID: 32651742


  63. Cohen BL, Gallinger ZR, Ha C, Holubar SD, Hou JK, Kinnucan J, Mahadevan U, Moss AC, Raffals LE, Regueiro M, Szigethy E, Wolf D, Dubinsky MC, Patel A, Shah BJ, Ehrlich OG, Hanauer SB. Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States. Inflammatory bowel diseases 2020. PMID: 32820340


  64. Lightner AL, Vogel JD, Carmichael JC, Keller DS, Shah SA, Mahadevan U, Kane SV, Paquette IM, Steele SR, Feingold DL. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease. Diseases of the colon and rectum 2020. PMID: 32692069


  65. LaHue SC, Anderson A, Krysko KM, Rutatangwa A, Dorsey MJ, Hale T, Mahadevan U, Rogers EE, Rosenstein MG, Bove R. Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases. Neurology(R) neuroimmunology & neuroinflammation 2020. PMID: 32461351


  66. Hammami MB, Mahadevan U. Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer. The American journal of gastroenterology 2020. PMID: 32022719


  67. Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, Gasche C, Silverberg MS, Mahadevan U, Sigall Boneh R, Wine E, Damas OM, Syme G, Trakman GL, Yao CK, Stockhamer SI, Hammami MB, Garces LC, Rogler G, Koutroubakis IE, Ananthakrishnan A, Liam M, Lewis JD. Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020. PMID: 32068150


  68. Ko MS, Rudrapatna VA, Avila P, Mahadevan U. Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease. Digestive diseases and sciences 2020. PMID: 32034603


  69. Lim J, Hammami MB, Mahadevan U. Infliximab Use in a Child with Ulcerative Colitis and Prior in utero Exposure to Infliximab. Gastroenterology 2020. PMID: 31926172


  70. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Erratum: Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Inflammatory bowel diseases 2019. PMID: 30947328


  71. Lewin SM, McConnell RA, Patel R, Sharpton SR, Velayos F, Mahadevan U. Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol. Inflammatory bowel diseases 2019. PMID: 30980712


  72. Mahadevan U, Fisher S, Riley L, Chambers C, Jain R, Robinson C. Reply to GASTRO-D-19-00915. Gastroenterology 2019. PMID: 31513796


  73. Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Hurtado-Lorenzo A, Heller CA. Challenges in IBD Research: Pragmatic Clinical Research. Inflammatory bowel diseases 2019. PMID: 31095704


  74. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. American journal of obstetrics and gynecology 2019. PMID: 30948039


  75. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Inflammatory bowel diseases 2019. PMID: 30821832


  76. Mao EJ, Sheibani S, Martin C, Bloomfeld RS, Isaacs K, Saha S, Mahadevan U. Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry. Inflammatory bowel diseases 2019. PMID: 30256951


  77. Hammami MB, Gill R, Thiruvengadam N, Oh DY, Beck K, Mahadevan U, Kattah MG. Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin. Digestive diseases and sciences 2019. PMID: 30778872


  78. Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, Friedman S, Kane S, Manthey J, Sauberan J, Stone J, Jain R. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology 2019. PMID: 30658060


  79. Lewin SM, Wen KW, Velayos FS, Mahadevan U, Beck KR. How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease. Digestive diseases and sciences 2019. PMID: 30523483


  80. Mahadevan U, Dubinsky MC, Su C, Lawendy N, Jones TV, Marren A, Zhang H, Graham D, Clowse MEB, Feldman SR, Baumgart DC. Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. Inflammatory bowel diseases 2018. PMID: 29982686


  81. Mao EJ, Mahadevan U. The Debate is Over: Continue Anti-Tumor Necrosis Factor Therapy Throughout Pregnancy. The American journal of gastroenterology 2018. PMID: 30337704


  82. Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics 2018. PMID: 29998501


  83. Kattah MG, Milush JM, Burt T, McCabe RP, Whang MI, Ma A, Mahadevan U. Correction: Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Clinical and translational gastroenterology 2018. PMID: 30065242


  84. Lichtenstein GR, Feagan BG, Mahadevan U, Salzberg BA, Langholff W, Morgan JG, Safdi M, Nissinen R, Taillard F, Sandborn WJ, Cohen RD. Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. The American journal of gastroenterology 2018. PMID: 30022113


  85. Kattah MG, Milush JM, Burt T, McCabe RP, Whang MI, Ma A, Mahadevan U. Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants. Clinical and translational gastroenterology 2018. PMID: 29618720


  86. Mahadevan U, Silverberg MS. Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review. Gastroenterology 2018. PMID: 29550591


  87. Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017. PMID: 28870657


  88. Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply. Alimentary pharmacology & therapeutics 2017. PMID: 28370036


  89. Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U. Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort. Digestive diseases and sciences 2017. PMID: 28332106


  90. Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. Alimentary pharmacology & therapeutics 2017. PMID: 28169436


  91. Colombel JF, Mahadevan U. Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms. Gastroenterology 2016. PMID: 27960091


  92. Mahadevan U, McConnell RA, Chambers CD. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease. Gastroenterology 2016. PMID: 27769809


  93. Mar JS, LaMere BJ, Lin DL, Levan S, Nazareth M, Mahadevan U, Lynch SV. Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients. Volume 7 of Issue 4. mBio 2016. PMID: 27531910


  94. McConnell RA, Mahadevan U. The Birds, the Bees, and Inflammatory Bowel Disease: Preconception Care in Inflammatory Bowel Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016. PMID: 27264392


  95. Cohan JN, Ozanne EM, Sewell JL, Hofer RK, Mahadevan U, Varma MG, Finlayson E. A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study. Volume 59 of Issue 6. Diseases of the colon and rectum 2016. PMID: 27145309


  96. McConnell RA, Mahadevan U. Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications. Gastroenterology clinics of North America 2016. PMID: 27261899


  97. Kathpalia P, Kane S, Mahadevan U. Detectable Drug Levels in Infants Exposed to Biologics: So What? Gastroenterology 2016. PMID: 27215654


  98. Carlucci JG, Halasa N, Creech CB, Dulek DE, Gómez-Duarte OG, Nelson GE, Talbot HK, Scalise ML, Scott PL, Mahadevan U, Beaulieu DB. Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy. Journal of the Pediatric Infectious Diseases Society 2016. PMID: 27012275


  99. Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U. The Effect of Maternal Peripartum Anti-TNFa Use on Infant Immune Response. Digestive diseases and sciences 2016. PMID: 26725061


  100. McConnell RA, Mahadevan U. Use of Immunomodulators and Biologics Before, During, and After Pregnancy. Inflammatory bowel diseases 2016. PMID: 26444103


  101. Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, Leontiadis GI, Tse F, Mahadevan U, van der Woude CJ. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 2015. PMID: 26688268


  102. Mahadevan U, Matro R. In Reply. Obstetrics and gynecology 2015. PMID: 26488508


  103. Clowse ME, Wolf DC, Förger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U. Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol. The Journal of rheumatology 2015. PMID: 26523031


  104. Mahadevan U, Matro R. Care of the Pregnant Patient With Inflammatory Bowel Disease. Obstetrics and gynecology 2015. PMID: 26241432


  105. Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. Arthritis care & research 2015. PMID: 25385050


  106. Matro R, Mahadevan U. Editorial: the management of IBD during pregnancy and lactation. Alimentary pharmacology & therapeutics 2014. PMID: 25303380


  107. Huang VW, Mahadevan U. A measured approach to Crohn's therapy: check levels and save. Gastroenterology 2014. PMID: 25240163


  108. Lin K, Mahadevan U. Pharmacokinetics of biologics and the role of therapeutic monitoring. Gastroenterology clinics of North America 2014. PMID: 25110259


  109. Hassid B, Mahadevan U. The use of biologic therapy in pregnancy: a gastroenterologist's perspective. Current opinion in rheumatology 2014. PMID: 24625373


  110. Hwang C, Ross V, Mahadevan U. Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit. Inflammatory bowel diseases 2014. PMID: 24562173


  111. Shah S, Terdiman J, Gundling K, Mahadevan U. Immunoglobulin therapy for refractory Crohn's disease. Therapeutic advances in gastroenterology 2014. PMID: 24587823


  112. Ng SW, Mahadevan U. My treatment approach to management of the pregnant patient with inflammatory bowel disease. Mayo Clinic proceedings 2014. PMID: 24582194


  113. Lin KK, Mahadevan U. Etrolizumab: anti-ß7-a novel therapy for ulcerative colitis. Gastroenterology 2013. PMID: 24269566


  114. Truta B, Li DX, Mahadevan U, Fisher ER, Chen YY, Grace K, Velayos F, Terdiman JP. Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis. Digestive diseases and sciences 2013. PMID: 24091907


  115. Sheibani S, Mahadevan U. Editorial: Are thiopurines and anti-TNFa agents safe to use in pregnant patients with inflammatory bowel disease? The American journal of gastroenterology 2013. PMID: 23459048


  116. Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Expert review of clinical immunology 2013. PMID: 23390947


  117. Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflammatory bowel diseases 2013. PMID: 22434610


  118. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012. PMID: 23200982


  119. Pak S, Holland N, Garnett EA, Mileti E, Mahadevan U, Beckert R, Kanwar B, Heyman MB. Cytokine profiles in peripheral blood of children and adults with Crohn disease. Volume 54 of Issue 6. Journal of pediatric gastroenterology and nutrition 2012. PMID: 22167015


  120. Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflammatory bowel diseases 2012. PMID: 22488830


  121. Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. Journal of Crohn's & colitis 2011. PMID: 22115383


  122. Leung Y, Heyman MB, Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist. Volume 17 of Issue 10. Inflammatory bowel diseases 2010. PMID: 21910179


  123. Mahadevan U, Cucchiara S, Hyams JS, Steinwurz F, Nuti F, Travis SP, Sandborn WJ, Colombel JF. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. The American journal of gastroenterology 2010. PMID: 21157441


  124. Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, Loke P. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Science translational medicine 2010. PMID: 21123809


  125. van der Woude CJ, Kolacek S, Dotan I, Oresland T, Vermeire S, Munkholm P, Mahadevan U, Mackillop L, Dignass A. European evidenced-based consensus on reproduction in inflammatory bowel disease. Journal of Crohn's & colitis 2010. PMID: 21122553


  126. Kwan LY, Mahadevan U. Inflammatory bowel disease and pregnancy: an update. Expert review of clinical immunology 2010. PMID: 20594137


  127. Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease. Gut 2010. PMID: 20551461


  128. Hou JK, Velayos F, Terrault N, Mahadevan U. Viral hepatitis and inflammatory bowel disease. Inflammatory bowel diseases 2010. PMID: 20480515


  129. El-Nachef N, Terdiman J, Mahadevan U. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation. The American journal of gastroenterology 2010. PMID: 20445523


  130. Baumgart DC, Targan SR, Dignass AU, Mayer L, van Assche G, Hommes DW, Hanauer SB, Mahadevan U, Reinisch W, Plevy SE, Salzberg BA, Buchman AL, Mechkov GM, Krastev ZA, Lowder JN, Frankel MB, Sandborn WJ. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Inflammatory bowel diseases 2010. PMID: 19714757


  131. Molloy JW, Kim E, Mahadevan U. Do side-by-side anastomoses decrease the risk of recurrence in Crohn's disease? Gastroenterology 2010. PMID: 20303965


  132. Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology 2010. PMID: 20064514


  133. Mahadevan U. Pregnancy and inflammatory bowel disease. The Medical clinics of North America 2010. PMID: 19944798


  134. Mahadevan U, Kane S. Use of infliximab in pregnancy. The American journal of gastroenterology 2010. PMID: 20054309


  135. Mahadevan U. Pregnancy and inflammatory bowel disease. Gastroenterology clinics of North America 2009. PMID: 19913206


  136. Sewell JL, Mahadevan U. Of blemishes and bowels: isotretinoin and inflammatory bowel disease. Gastroenterology 2009. PMID: 19932213


  137. Mahadevan U. Cervical neoplasia risk in IBD: truth or hysteria? Inflammatory bowel diseases 2009. PMID: 19408322


  138. Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflammatory bowel diseases 2009. PMID: 19591135


  139. McCabe JM, Mahadevan U, Vidyarthi A. An obscure harbinger. Difficult diagnosis of Crohn's Disease. The American journal of medicine 2009. PMID: 19486711


  140. Sewell JL, Mahadevan U. A new answer to an old question: azathioprine withdrawal in quiescent Crohn's disease. Gastroenterology 2009. PMID: 19482103


  141. Hou JK, Mahadevan U. A 24-year-old pregnant woman with inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009. PMID: 19410016


  142. Costouros NG, Niho H, Mahadevan U, Kerlan RK, Bloom AI. Angiographic embolization for control of life-threatening hemorrhage from benign rectal ulcers. Journal of vascular and interventional radiology : JVIR 2009. PMID: 19246210


  143. Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bernstein CN, Sandborn WJ. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflammatory bowel diseases 2009. PMID: 18668682


  144. Sewell JL, Mahadevan U. Infliximab and surgical complications: truth or perception? Gastroenterology 2008. PMID: 19059260


  145. Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflammatory bowel diseases 2008. PMID: 18626967


  146. Mahadevan U. Continuing immunomodulators and biologic medications in pregnant IBD patients - pro. Inflammatory bowel diseases 2007. PMID: 17763475


  147. Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U, Frankel M, Lowder J. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology 2007. PMID: 17920064


  148. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007. PMID: 17764676


  149. Velayos F, Mahadevan U. Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007. PMID: 17544992


  150. Mahadevan U. Gastrointestinal medications in pregnancy. Best practice & research. Clinical gastroenterology 2007. PMID: 17889812


  151. Mahadevan U. TNF-alpha antagonists: benefits beyond remission. Reviews in gastroenterological disorders 2007. PMID: 17392633


  152. Mahadevan U. Pregnancy, Fertility, and Therapies for IBD. Gastroenterology & hepatology 2006. PMID: 28286451


  153. Mahadevan U. Mucosal healing in Crohn's disease: what you see is what you get? Gastrointestinal endoscopy 2006. PMID: 16500393


  154. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 2005. PMID: 15888806


  155. Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflammatory bowel diseases 2005. PMID: 15803031


  156. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Alimentary pharmacology & therapeutics 2005. PMID: 15771759


  157. Gill KR, Mahadevan U. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease. Inflammatory bowel diseases 2005. PMID: 15677920


  158. Mahadevan U. Medical treatment of ulcerative colitis. Clinics in colon and rectal surgery 2004. PMID: 20011280


  159. Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Alimentary pharmacology & therapeutics 2003. PMID: 14616166


  160. Mahadevan U. 6TG: when less is more than you bargained for. Inflammatory bowel diseases 2003. PMID: 14677541


  161. Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflammatory bowel diseases 2003. PMID: 14671483


  162. Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology 2003. PMID: 12761722


  163. Mahadevan U, Loftus EV, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflammatory bowel diseases 2002. PMID: 12479645


  164. Mahadevan U, Loftus EV, Tremaine WJ, Sandborn WJ. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. The American journal of gastroenterology 2002. PMID: 12008668


  165. Mahadevan U, Sandborn WJ. Evolving medical therapies for Crohn's disease. Current gastroenterology reports 2001. PMID: 11696284


  166. Mahadevan U, Sandborn WJ. Infliximab for the treatment of orofacial Crohn's disease. Inflammatory bowel diseases 2001. PMID: 11233659


  167. Mahadevan U, Tremaine WJ, Johnson T, Pike MG, Mays DC, Lipsky JJ, Sandborn WJ. Intravenous azathioprine in severe ulcerative colitis: a pilot study. The American journal of gastroenterology 2000. PMID: 11151878